Clinical Trials Browser

INDUSTRY × Doxorubicin × Sarcoma × Clear all

NCT06088290 2026-03-11

SaLuDo

Phase 3 Recruiting

Leiomyosarcoma, Neoplasms

NCT05218499 2026-03-02

Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

Phase 2/3 Completed

400 enrolled 15 charts

Liposarcoma

NCT05481645 2026-01-09

Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

Phase 2 Terminated

GynecologicSarcoma

Advanced Endometrial Cancer

NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Phase 1 Completed

Sarcoma

NCT02451943 2025-07-15

ANNOUNCE

Phase 3 Completed

509 enrolled 23 charts

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT05100628 2025-01-06

A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

Phase 1 Terminated

9 enrolled 10 charts

Sarcoma

NCT04996004 2024-12-11

TTI-621-03

Phase 2 Terminated

76 enrolled 53 charts

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

NCT05824975 2024-11-25

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Phase 1/2 Recruiting

DermatologicGastrointestinalGenitourinarySarcoma

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT06500091 2024-07-15

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

Phase 2 Not yet recruiting

DermatologicSarcoma

Melanoma, Sarcoma

NCT02049905 2024-06-13

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Phase 3 Completed

433 enrolled 10 charts

Neoplasm Metastasis, Sarcoma

NCT01514188 2024-05-29

Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

Phase 2 Completed

126 enrolled 13 charts

Neoplasm Metastasis, Sarcoma

NCT04032964 2024-04-08

DOXO75

Phase 1 Active not recruiting

Sarcoma

NCT04650984 2024-04-08

FIBROSARC

Phase 3 Recruiting

Sarcoma

NCT03420014 2023-10-10

FIBROSARC US

Phase 2 Unknown

Leiomyosarcoma

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma

NCT02076620 2022-04-04

L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Phase 1 Completed

Breast Neoplasms, Sarcoma

NCT05138146 2021-11-30

A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

Phase 2 Unknown

Sarcoma

NCT03283696 2020-09-10

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Phase 1 Completed

24 enrolled 21 charts

Sarcoma

NCT02326025 2019-11-21

A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma

Phase 1 Completed

49 enrolled 17 charts

Sarcoma

NCT03002805 2019-08-19

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Phase 1 Unknown

Sarcoma

NCT02783599 2019-08-12

A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Phase 1 Completed

51 enrolled 22 charts

Sarcoma

NCT02255110 2018-12-14

A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Phase 2 Terminated

6 enrolled 6 charts

Sarcoma

NCT00484341 2018-08-29

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Phase 2 Completed

Sarcoma

NCT00960063 2018-08-27

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Phase 1 Terminated

4 enrolled 8 charts

CNSGenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Neoplasms, Neuroblastoma

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Phase 1 Completed

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT01185964 2017-04-14

A Study of Olaratumab in Soft Tissue Sarcoma

Phase 1/2 Completed

148 enrolled 21 charts

Sarcoma

NCT01605526 2016-11-02

A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma

Phase 1 Completed

Sarcoma

NCT01440088 2016-06-02

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Phase 3 Completed

Sarcoma

NCT00796120 2015-12-10

An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

Phase 3 Completed

121 enrolled 10 charts

Sarcoma

NCT00878800 2015-07-28

A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

Phase 1/2 Completed

41 enrolled 18 charts

Sarcoma

NCT00288431 2015-07-22

Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)

Phase 1 Completed

Neoplasms, Sarcoma

NCT00718484 2014-01-30

PICASSO

Phase 2 Unknown

Sarcoma

NCT01168791 2013-07-18

PICASSO III

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

NCT00102609 2013-01-10

A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma

Phase 1 Completed

Neoplasms, Neoplasms by Histologic Type, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT00002093 2005-06-24

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002105 2005-06-24

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002147 2005-06-24

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002318 2005-06-24

A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

Phase 3 Unknown

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002319 2005-06-24

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections